SS Innovations International (SSII) Convertible Debt (2023 - 2024)
SS Innovations International (SSII) posted Convertible Debt of $58144.0 for Q3 2024, up 71.35% sequentially from $33933.0 in Q4 2023.
SS Innovations International (SSII) Convertible Debt (2023 - 2024) Analysis & Trends
SS Innovations International has reported Convertible Debt for 2 years, with the latest figure at $58144.0 in Q3 2024.
- Quarterly Convertible Debt changed N/A year-over-year to $58144.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $58144.0 (changed N/A YoY) and the FY2023 annual result came in at $33933.0, changed N/A from the prior year.
- Convertible Debt improved to $58144.0 in Q3 2024 per SSII's latest filing, from $33933.0 in the prior quarter.
- Over five years, Convertible Debt peaked at $58144.0 in Q3 2024 and troughed at $33933.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | SS Innovations International | 714.49 Mn | 692.19 Mn | 7.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 58,144.00 |
| Dec 31, 2023 | 33,933.00 |